0000899243-22-004607.txt : 20220203
0000899243-22-004607.hdr.sgml : 20220203
20220203163041
ACCESSION NUMBER: 0000899243-22-004607
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220201
FILED AS OF DATE: 20220203
DATE AS OF CHANGE: 20220203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waisbourd Ram
CENTRAL INDEX KEY: 0001792064
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 22588863
MAIL ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 4155004614
MAIL ADDRESS:
STREET 1: 535 MISSION STREET
STREET 2: 14TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-01
0
0001785173
89bio, Inc.
ETNB
0001792064
Waisbourd Ram
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
0
1
0
0
See Remarks
Common Stock
2022-02-01
4
M
0
4000
1.93
A
4000
D
Common Stock
2022-02-01
4
M
0
3000
1.93
A
7000
D
Common Stock
2022-02-01
4
S
0
7000
5.70
D
0
D
Stock Option (Right to Buy)
1.93
2022-02-01
4
M
0
4000
0.00
D
2028-11-09
Common Stock
4000
14203
D
Stock Option (Right to Buy)
1.93
2022-02-01
4
M
0
3000
0.00
D
2029-10-01
Common Stock
3000
3106
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $5.43 to $5.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
This option represents a right to purchase a total of 20,106 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
Chief Operating Officer and Chief Business Officer
/s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
2022-02-03